This model recapitulates several key features observed in tauopathies, including progressive cognitive decline, synaptic dysfunction, and tau pathology, without the confounding effects of motor deficits often seen in other transgenic lines [15]. The gene discussed is MAPT; the disease is Mental deterioration.